Laura Soucek receives an ERC Advanced Grant to maximize the clinical and preclinical use of the first viable MYC inhibitor

by VHIO

Laura Soucek, an ICREA Research Professor, Director of VHIO’s Experimental Therapeutics Program, and Head of our Models of Cancer Therapies Group, has received a European Research Council (ERC) Adv...

Read more

MYC inhibition in melanoma: preclinical promise and the unveiling of a pronostic gene signature

by VHIO

Results suggest that Omomyc MYC-targeted therapy could potentially open up a new treatment avenue for melanoma, and point to the future development of clinical trials to assess the efficacy of this mi...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palex and Duomed to create the first tru...

by Palex Medical

Palex Medical has announced the execution of a put option agreement fo...

Photos Stream